AccScience Publishing / TD / Online First / DOI: 10.36922/td.8465
LETTER TO EDITOR

Dosiomics in lung cancer

Melek Yakar1*
Show Less
1 Department of Radiation Oncology, Faculty of Medicine, Osmangazi University, Eskişehir, Turkey
Tumor Discovery, 8465 https://doi.org/10.36922/td.8465
Submitted: 9 January 2025 | Accepted: 14 January 2025 | Published: 31 January 2025
© 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Conflict of interest
The author declares that she has no conflict of interest and has no competing interests.
References
  1. Dudas D, Dilling TJ, Naqa IE. A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients. Radiat Oncol. 2024;19(1):127. doi: 10.1186/s13014-024-02519-1

 

  1. Ma Z, Liang B, Wei R, et al. Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial. Thorac Cancer. 2023;14(28):2839-2845. doi: 10.1111/1759-7714.15068

 

  1. Zhou L, Wen Y, Zhang G, Wang L, Wu S, Zhang S. machine learning-based multiomics prediction model for radiation pneumonitis. J Oncol. 2023;2023:5328927. doi: 10.1155/2023/5328927

 

  1. Adachi T, Nakamura M, Shintani T, et al. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy. Med Phys. 2021;48(4):1781-1791. doi: 10.1002/mp.14769

 

  1. Monti S, Xu T, Liao Z, Mohan R, Cella L, Palma G. On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients. Radiother Oncol. 2022;167:219-225. doi: 10.1016/j.radonc.2021.12.038

 

  1. Puttanawarut C, Sirirutbunkajorn N, Tawong N, et al. Radiomic and dosiomic features for the prediction of radiation pneumonitis across esophageal cancer and lung cancer. Front Oncol. 2022;12:768152. doi: 10.3389/fonc.2022.768152

 

  1. Zhang Z, Wang Z, Yan M, et al. Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis: A model development study with prospective external validation and decision-curve analysis. Int J Radiat Oncol Biol Phys. 2023;115(3):746-758. doi: 10.1016/j.ijrobp.2022.08.047

 

  1. Bhandari A, Johnson K, Oh K, et al. Developing a novel dosiomics model to predict treatment failures following lung stereotactic body radiation therapy. Front Oncol. 2024;14:1438861. doi: 10.3389/fonc.2024.1438861
Share
Back to top
Tumor Discovery, Electronic ISSN: 2810-9775 Print ISSN: 3060-8597, Published by AccScience Publishing